251 related articles for article (PubMed ID: 27804231)
21. Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression.
Rades D; Rudat V; Veninga T; Stalpers LJ; Hoskin PJ; Schild SE
Cancer; 2008 Sep; 113(5):1090-6. PubMed ID: 18642349
[TBL] [Abstract][Full Text] [Related]
22. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors.
Rades D; Huttenlocher S; Bajrovic A; Karstens JH; Adamietz IA; Kazic N; Rudat V; Schild SE
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e861-8. PubMed ID: 21277114
[TBL] [Abstract][Full Text] [Related]
23. Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials.
Rades D; Cacicedo J; Conde-Moreno AJ; Segedin B; Lomidze D; Ciervide R; Hollaender NH; Schild SE
Radiat Oncol; 2021 Jan; 16(1):7. PubMed ID: 33413492
[TBL] [Abstract][Full Text] [Related]
24. High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): a multicenter phase 2 study.
Rades D; Cacicedo J; Conde-Moreno AJ; Doemer C; Dunst J; Lomidze D; Segedin B; Olbrich D; Holländer NH
BMC Cancer; 2017 Dec; 17(1):818. PubMed ID: 29202720
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer.
Rades D; Stalpers LJ; Veninga T; Rudat V; Schulte R; Hoskin PJ
J Urol; 2006 Feb; 175(2):552-6. PubMed ID: 16406994
[TBL] [Abstract][Full Text] [Related]
26. Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients.
Rades D; Douglas S; Veninga T; Bajrovic A; Stalpers LJ; Hoskin PJ; Rudat V; Schild SE
Strahlenther Onkol; 2012 Jun; 188(6):472-6. PubMed ID: 22361746
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy for metastatic spinal cord compression; can the Rades score predict survival?
Kerstens P; Yi M; James M
Asia Pac J Clin Oncol; 2019 Dec; 15(6):331-336. PubMed ID: 31436904
[TBL] [Abstract][Full Text] [Related]
28. Short-course radiotherapy is not optimal for spinal cord compression due to myeloma.
Rades D; Hoskin PJ; Stalpers LJ; Schulte R; Poortmans P; Veninga T; Dahm-Daphi J; Obralic N; Wildfang I; Bahrehmand R; Engenhart-Cabilic R; Schild SE
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1452-7. PubMed ID: 16413695
[TBL] [Abstract][Full Text] [Related]
29. Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study.
Rades D; Walz J; Stalpers LJ; Veninga T; Schulte R; Obralic N; Wildfang I; Engenhart-Cabilic R; Hoskin PJ; Schild SE
Eur Urol; 2006 May; 49(5):846-52; discussion 852. PubMed ID: 16442206
[TBL] [Abstract][Full Text] [Related]
30. Comparison of 1 x 8 Gy and 10 x 3 Gy for functional outcome in patients with metastatic spinal cord compression.
Rades D; Stalpers LJ; Hulshof MC; Borgmann K; Karstens JH; Koning CC; Alberti W
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):514-8. PubMed ID: 15890595
[TBL] [Abstract][Full Text] [Related]
31. Survival in patients with metastatic spinal cord compression from prostate cancer is associated with the number of extra-spinal organs involved.
Weber A; Bartscht T; Karstens JH; Schild SE; Rades D
Anticancer Res; 2013 Oct; 33(10):4505-7. PubMed ID: 24123022
[TBL] [Abstract][Full Text] [Related]
32. Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases.
Rades D; Veninga T; Stalpers LJ; Basic H; Rudat V; Karstens JH; Dunst J; Schild SE
J Clin Oncol; 2007 Jan; 25(1):50-6. PubMed ID: 17194905
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression.
Rades D; Douglas S; Veninga T; Stalpers LJ; Bajrovic A; Rudat V; Schild SE
Strahlenther Onkol; 2012 Apr; 188(4):340-5. PubMed ID: 22354333
[TBL] [Abstract][Full Text] [Related]
34. A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression.
Rades D; Rudat V; Veninga T; Stalpers LJ; Basic H; Karstens JH; Hoskin PJ; Schild SE
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):905-8. PubMed ID: 18436390
[TBL] [Abstract][Full Text] [Related]
35. A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression.
Rades D; Conde-Moreno AJ; Cacicedo J; Veninga T; Segedin B; Stanic K; Schild SE
Radiat Oncol; 2018 Dec; 13(1):257. PubMed ID: 30594231
[TBL] [Abstract][Full Text] [Related]
36. Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors.
Rades D; Freundt K; Meyners T; Bajrovic A; Basic H; Karstens JH; Adamietz IA; Wildfang I; Rudat V; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1492-7. PubMed ID: 20579816
[TBL] [Abstract][Full Text] [Related]
37. Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy.
Rades D; Segedin B; Schild SE; Lomidze D; Veninga T; Cacicedo J
Radiat Oncol; 2022 Aug; 17(1):143. PubMed ID: 35978340
[TBL] [Abstract][Full Text] [Related]
38. DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC).
Souchon R; Wenz F; Sedlmayer F; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sautter-Bihl ML; Sauer R;
Strahlenther Onkol; 2009 Jul; 185(7):417-24. PubMed ID: 19714302
[TBL] [Abstract][Full Text] [Related]
39. Do bladder cancer patients with metastatic spinal cord compression benefit from radiotherapy alone?
Rades D; Walz J; Schild SE; Veninga T; Dunst J
Urology; 2007 Jun; 69(6):1081-5. PubMed ID: 17572191
[TBL] [Abstract][Full Text] [Related]
40. Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients.
Rades D; Stalpers LJ; Schulte R; Veninga T; Basic H; Engenhart-Cabilic R; Schild SE; Hoskin PJ
Eur J Cancer; 2006 May; 42(8):1052-6. PubMed ID: 16580192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
